A Redox‐active Mn Porphyrin, MnTnBuOE‐2‐PyP5+, Synergizes with Carboplatin in Treatment of Chemoresistant Ovarian Cell Line
L Chaiswing, C Yarana, W St. Clair… - Oxidative Medicine …, 2022 - Wiley Online Library
We have employed a redox‐active MnP (MnTnBuOE‐2‐PyP5+, Mn (III) meso‐tetrakis (N‐n‐
butoxyethylpyridinium‐2‐yl) porphyrin) frequently identified as superoxide dismutase mimic …
butoxyethylpyridinium‐2‐yl) porphyrin) frequently identified as superoxide dismutase mimic …
A Redox-active Mn Porphyrin, MnTnBuOE-2-PyP5+, Synergizes with Carboplatin in Treatment of Chemoresistant Ovarian Cell Line
L Chaiswing, C Yarana, WS Clair… - Oxidative …, 2022 - mahidol.elsevierpure.com
We have employed a redox-active MnP (MnTnBuOE-2-PyP5+, Mn (III) meso-tetrakis (Nn-
butoxyethylpyridinium-2-yl) porphyrin) frequently identified as superoxide dismutase mimic …
butoxyethylpyridinium-2-yl) porphyrin) frequently identified as superoxide dismutase mimic …
A Redox-active Mn Porphyrin, MnTnBuOE-2-PyP5+, Synergizes with Carboplatin in Treatment of Chemoresistant Ovarian Cell Line.
L Chaiswing, C Yarana, W St Clair… - … Medicine and Cellular …, 2022 - europepmc.org
We have employed a redox-active MnP (MnTnBuOE-2-PyP 5+, Mn (III) meso-tetrakis (Nn-
butoxyethylpyridinium-2-yl) porphyrin) frequently identified as superoxide dismutase mimic …
butoxyethylpyridinium-2-yl) porphyrin) frequently identified as superoxide dismutase mimic …
A Redox-active Mn Porphyrin, MnTnBuOE-2-PyP5+, Synergizes with Carboplatin in Treatment of Chemoresistant Ovarian Cell Line
L Chaiswing, C Yarana, W St Clair… - Oxidative medicine …, 2022 - pubmed.ncbi.nlm.nih.gov
We have employed a redox-active MnP (MnTnBuOE-2-PyP 5+, Mn (III) meso-tetrakis (Nn-
butoxyethylpyridinium-2-yl) porphyrin) frequently identified as superoxide dismutase mimic …
butoxyethylpyridinium-2-yl) porphyrin) frequently identified as superoxide dismutase mimic …
[PDF][PDF] Research Article A Redox-active Mn Porphyrin, MnTnBuOE-2-PyP 5, Synergizes with Carboplatin in Treatment of Chemoresistant Ovarian Cell Line
L Chaiswing, C Yarana, WS Clair, A Tovmasyan… - 2022 - scienceopen.com
We have employed a redox-active MnP (MnTnBuOE-2-PyP5+, Mn (III) meso-tetrakis (Nn-
butoxyethylpyridinium-2-yl) porphyrin) frequently identified as superoxide dismutase mimic …
butoxyethylpyridinium-2-yl) porphyrin) frequently identified as superoxide dismutase mimic …
[HTML][HTML] A Redox-active Mn Porphyrin, MnTnBuOE-2-PyP5+, Synergizes with Carboplatin in Treatment of Chemoresistant Ovarian Cell Line
L Chaiswing, C Yarana, WS Clair… - … Medicine and Cellular …, 2022 - ncbi.nlm.nih.gov
We have employed a redox-active MnP (MnTnBuOE-2-PyP 5+, Mn (III) meso-tetrakis (Nn-
butoxyethylpyridinium-2-yl) porphyrin) frequently identified as superoxide dismutase mimic …
butoxyethylpyridinium-2-yl) porphyrin) frequently identified as superoxide dismutase mimic …
A Redox-active Mn Porphyrin, MnTnBuOE-2-PyP5+, Synergizes with Carboplatin in Treatment of Chemoresistant Ovarian Cell Line
L Chaiswing, C Yarana, W St Clair… - Oxidative Medicine …, 2022 - search.proquest.com
We have employed a redox-active MnP (MnTnBuOE-2-PyP 5+, Mn (III) meso-tetrakis (Nn-
butoxyethylpyridinium-2-yl) porphyrin) frequently identified as superoxide dismutase mimic …
butoxyethylpyridinium-2-yl) porphyrin) frequently identified as superoxide dismutase mimic …